The ability of the AI chatbot GPT-4 to appropriately perform probabilistic reasoning in diagnosis vs a large survey of human clinicians

Cidara reports deal with Janssen is still in effect despite Janssen’s announcement to discontinue the internal development of much of its infectious disease pipeline, including

Har­mo­ny Bio­sciences is pay­ing $60 mil­lion in cash to get its hands on Zyner­ba Phar­ma­ceu­ti­cals and a ther­a­py it’s de­vel­op­ing to treat two rare dis­eases.